These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8990503)

  • 1. The effect of topical steroid on the actions of vasoconstrictor and vasodilator peptides in human skin.
    Goldsmith P; Bunker C; Leslie T; Foreman J; Dowd PM
    Skin Pharmacol; 1996; 9(5):289-97. PubMed ID: 8990503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of topically applied clobetasol-17-propionate on histamine release in human skin.
    Ståhle M; Hägermark O
    Acta Derm Venereol; 1984; 64(3):239-42. PubMed ID: 6204486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced skin reactivity to vasoconstrictor and vasodilator substances in atopic eczema.
    Zirbs M; Reindel U; Hermann K; Church MK; Behrendt H; Ring J; Brockow K
    Eur J Dermatol; 2013; 23(6):812-9. PubMed ID: 24201043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effects.
    Kerscher MJ; Korting HC; Mehringer L; Mätzig R
    Skin Pharmacol; 1996; 9(2):120-3. PubMed ID: 8722606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by glucocorticoids of the mast cell-dependent weal and flare response in human skin in vivo.
    Cole ZA; Clough GF; Church MK
    Br J Pharmacol; 2001 Jan; 132(1):286-92. PubMed ID: 11156588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.
    Singh S; Gupta A; Pandey SS; Singh G
    Dermatology; 1996; 193(2):121-3. PubMed ID: 8884147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of topical steroids on cutaneous oxygen tension.
    Haria M; O'Neill RC; Wright S
    Br J Dermatol; 1992 May; 126(5):502-4. PubMed ID: 1610691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous responses to endothelin-1 and histamine in patients with vibration white finger.
    Dowd PM; Goldsmith PC; Chopra S; Bull HA; Foreman JC
    J Invest Dermatol; 1998 Feb; 110(2):127-31. PubMed ID: 9457906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids.
    Seidenari S; Di Nardo A; Mantovani L; Giannetti A
    Exp Dermatol; 1997 Apr; 6(2):75-80. PubMed ID: 9209888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study.
    Singh SK; Nasir F
    Indian J Dermatol Venereol Leprol; 2015; 81(4):370-5. PubMed ID: 26144851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the vasoconstrictive effects of topical steroids by laser-Doppler-perfusion-imaging.
    Sommer A; Veraart J; Neumann M; Kessels A
    Acta Derm Venereol; 1998 Jan; 78(1):15-8. PubMed ID: 9498019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-induced vasoconstriction in human skin. An inhibitory role on phospholipase A2 activity.
    Marks R; Sawyer M
    Arch Dermatol; 1986 Aug; 122(8):881-3. PubMed ID: 2874773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcipotriol and clobetasol-17-propionate on UVB-irradiated human skin: an immunohistochemical study.
    van der Vleuten CJ; Snijders CG; de Jong EM; van de Kerkhof PC
    Skin Pharmacol; 1996; 9(6):355-65. PubMed ID: 9055356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations.
    Feldman SR; Yentzer BA
    Am J Clin Dermatol; 2009; 10(6):397-406. PubMed ID: 19824740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoconstrictive effect of topical applied corticosteroids measured by laser doppler imaging and reflectance spectroscopy.
    Sommer A; Lucassen GW; Houben AJ; Neumann MH
    Microvasc Res; 2003 May; 65(3):152-9. PubMed ID: 12711256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid-induced dermal thinning: discontinuous application of clobetasol-17-propionate ointment.
    Lubach D; Rath J; Kietzmann M
    Dermatology; 1992; 185(1):44-8. PubMed ID: 1638070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
    Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
    Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of substance P and calcitonin gene-related peptide in human skin--a microdialysis study.
    Weidner C; Klede M; Rukwied R; Lischetzki G; Neisius U; Skov PS; Petersen LJ; Schmelz M
    J Invest Dermatol; 2000 Dec; 115(6):1015-20. PubMed ID: 11121135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic dermographism: wealing, mast cells and histamine are decreased in the skin following long-term application of a potent topical corticosteroid.
    Lawlor F; Black AK; Murdoch RD; Greaves MW
    Br J Dermatol; 1989 Nov; 121(5):629-34. PubMed ID: 2597634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
    Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.